Venture Leaders Biotech 2021

The Venture Leaders program connects the top ten Swiss startups in Biotech to Boston’s world class life sciences ecosystem. Meeting with local experts and investors, the Swiss entrepreneurs immerse themselves in the US market to accelerate their business growth.

Every year, Venturelab selects the 10 best startups in Biotech to participate in an intensive investor roadshow in Boston. Swissnex in Boston partners with the Venture Leaders to provide access to local experts for business feedback as well as mentoring, coaching, and investment.

The Venture Leaders program has been coming to Boston for 16 years and is a much anticipated event in the local ecosystem. Notable alumni include Covagen (acquired by Johnson & Johnson), Redbiotec (partly acquired by Pfizer), KB Medical (acquired by Globus Medical), SimplicityBio (acquired by Precision for Medicine), and AMAL Therapeutics (acquired by Boehringer Ingelheim)

Interested in meeting any of the Swiss Venture Leaders? Contact Swissnex to learn more.


This program takes place from November 8 – 12, 2021

Monday, November 8

  • Pitch coaching
  • Expert roundtables

Tuesday, November 9

Wednesday – Friday, November 10 – 12

  • Private investor meetings


Venture Leaders in Biotech is an initiative of Venturelab organized by Swissnex in Boston and supported by Vischer Swiss Law and Tax, EPFL, ETH Zurich, and the Canton of Zurich.